In our initial transitional monocytes system that mimic the responses of tumor-associated monocytes/macrophages under IFN-based therapy (Fig. 1), we have demonstrated the involvement of IL-4 and IL-6 in mediating the IFN-elicited, unconventional M2 program. The gene discussed is IL6; the disease is neoplasm.